Table 3.
Demographic and clinical characteristics of Bethesda III patients by histopathologic result (n = 59)
| Characteristics | All patients (n = 59), N(%) | Malignant (n = 38), N(%) | Benign (n = 21), N(%) | P |
|---|---|---|---|---|
| Age (in years), mean ± SD | 46.64 ± 11.52 | 46.68 ± 12.34 | 46.57 ± 10.14 | 0.972 |
| Sex | 0.438 | |||
| Female | 51 (86) | 34 (67) | 17 (33) | |
| Male | 8 (14) | 4 (50) | 4 (40) | |
| Past medical history | ||||
| Malignancy | ||||
| Without | 54 (92) | 35 (65) | 19 (35) | 1.000 |
| With | 5 (8) | 3 (60) | 2 (40) | |
| Malignancy: Head and neck | ||||
| Without | 59 (100) | 38 (100) | 21 (100) | |
| With | 0 | 0 | 0 | |
| Thyroid disease | ||||
| Without | 58 (98) | 37 (64) | 21 (36) | 1.000 |
| With | 1 (2) | 1 (100) | 0 | 0.438 |
| Family history: Thyroid dysfunction | ||||
| No | 51 (86) | 34 (67) | 17 (33) | 0.438 |
| Yes | 8 (14) | 4 (50) | 4 (50) | 0.646 |
| Family history: Thyroid malignancy | 0.646 | |||
| No | 54 (92) | 34 (63) | 20 (37) | |
| Yes | 5 (8) | 4 (80) | 1 (20) | |
| TSH (in mIU/L)a | ||||
| median | 1.25 | 1.24 | 1.63 | 0.7840 |
| IQR | 0.81-1.94 | 0.86-1.9 | 0.69-2.69 | |
| Low | 5 (10) | 3 (60) | 2 (40) | 0.085 |
| Normal | 44 (87) | 32 (73) | 12 (27) | - |
| High | 2 (4) | 0 | 2 (100) | |
| History of radiation | ||||
| No | 59 (100) | 38 (64) | 21 (36) | 1.000 |
| Yes | 0 | 0 | 0 | |
| Presence of obstructive symptoms | 1.000 | |||
| No | 54 (92) | 35 (65) | 19 (35) | 0.733 |
| Yes | 5 (8) | 3 (60) | 2 (40) | |
| Thyroid Medications | ||||
| No | 49 (83) | 32 (65) | 17 (35) | |
| Yes | 10 (17) | 6 (60) | 4 (40) | |
a
Only 51 patients have data for TSH